Dunn Edmund 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Dunn Edmund
Principal Accounting Officer
Transactions
- Sale
Common Stock
2024-06-03$4.04/sh−1,207$4,876→ 15,554 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.0111 to $4.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.